Nutritional reprogramming of mouse liver proteome is dampened by metformin, resveratrol, and rapamycin

Cell Metab. 2021 Dec 7;33(12):2367-2379.e4. doi: 10.1016/j.cmet.2021.10.016. Epub 2021 Nov 11.

Abstract

Nutrient sensing pathways influence metabolic health and aging, offering the possibility that diet might be used therapeutically, alone or with drugs targeting these pathways. We used the Geometric Framework for Nutrition to study interactive and comparative effects of diet and drugs on the hepatic proteome in mice across 40 dietary treatments differing in macronutrient ratios, energy density, and drug treatment (metformin, rapamycin, resveratrol). There was a strong negative correlation between dietary energy and the spliceosome and a strong positive correlation between dietary protein and mitochondria, generating oxidative stress at high protein intake. Metformin, rapamycin, and resveratrol had lesser effects than and dampened responses to diet. Rapamycin and metformin reduced mitochondrial responses to dietary protein while the effects of carbohydrates and fat were downregulated by resveratrol. Dietary composition has a powerful impact on the hepatic proteome, not just on metabolic pathways but fundamental processes such as mitochondrial function and RNA splicing.

Keywords: Geometric Framework; Nutrition; caloric restriction; liver; macronutrients; metformin; mitochondria; proteome; rapamycin; resveratrol; spliceosome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Liver* / drug effects
  • Liver* / metabolism
  • Metformin* / pharmacology
  • Mice
  • Proteome* / metabolism
  • Resveratrol* / pharmacology
  • Sirolimus* / pharmacology

Substances

  • Proteome
  • Metformin
  • Resveratrol
  • Sirolimus